Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the period ending March 31, 2021. The report details a capital increase approved by the Board of Directors on March 29, 2021, resulting from the exercise of stock options under the "First Program for the year of 2016 of the Company's Stock Option Plan."
Key Financial Metrics
The filing does not provide standard operating financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on capital structure changes and historical share pricing.
- Capital Increase Amount: BRL 73,189,946.00
- New Capital Stock: BRL 57,972,262,719.68
- Shares Issued: 4,010,408 new common shares (no par value)
- Issuance Price: BRL 18.25 per share
Material Changes
The primary material change is the issuance of 4,010,408 new common shares. This action increased the company's capital stock to approximately BRL 57.97 billion. The filing includes historical market price data for the last three years, two years (quarterly), and six months (monthly), noting that prices are adjusted for interest on own capital and dividend distributions.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, or discussion of risks and contingencies. It is a procedural notice regarding the homologation of a capital increase pursuant to Brazilian Law No. 6,404/76 and the Company's Bylaws.
Investor Verification Checklist
- Verify the impact of the 0.025487% potential dilution on existing share ownership.
- Confirm the final updated share count and capital stock value in subsequent filings.
- Review the terms of the "First Program for the year of 2016 of the Company's Stock Option Plan" to understand the vesting and exercise conditions.
- Check for any related tax implications of the capital increase for shareholders.